{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:05:50Z","timestamp":1792800350702,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"The Percy Falk Foundation","id":[{"id":"https:\/\/ror.org\/05t4nvn27","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Mrs Berta Kamprad Foundation"},{"DOI":"10.13039\/501100003173","name":"The Crafoord Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001862","name":"The Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Swedish Cancer Society","id":[{"id":"https:\/\/ror.org\/0527jb766","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Royal Academy of Sciences","id":[{"id":"https:\/\/ror.org\/02zzhpq74","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Royal Physiographical Society"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2142-3","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T07:21:11Z","timestamp":1456212071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs"],"prefix":"10.1186","volume":"16","author":[{"given":"Xiaoli","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Borgstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kempengren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Hegardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Strand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stina","family":"Oredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,23]]},"reference":[{"key":"2142_CR1","doi-asserted-by":"crossref","unstructured":"Brewster AM, Hortobagyi GN, Broglio KR, Kau S-W, Santa-Maria CA, Arun B, Buzdar AU, Booser DJ, Valero V, Bondy M, Esteva FJ. Residual risk of breast cancer recurrence 5\u00a0years after adjuvant therapy. J Natl Cancer Inst. 2008;100:1179\u201383.","DOI":"10.1093\/jnci\/djn233"},{"key":"2142_CR2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.cellbio.22.010305.104154","volume":"23","author":"NA Lobo","year":"2007","unstructured":"Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol. 2007;23:675\u201399.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2142_CR3","doi-asserted-by":"crossref","unstructured":"Abubaker K, Latifi A, Luwor R, Nazaretian S, Zhu H, Quinn MA, Thompson EW, Findlay JK, Ahmed N. Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. Mol Cancer. 2013;12:24.","DOI":"10.1186\/1476-4598-12-24"},{"key":"2142_CR4","doi-asserted-by":"crossref","unstructured":"Craveiro V, Yang-Hartwich Y, Holmberg JC, Sumi NJ, Pizzonia J, Griffin B, Gill SK, Silasi D-A, Azodi M, Rutherford T, Alvero AB, Mor G. Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment. Cancer Med. 2013;2:751\u201362.","DOI":"10.1002\/cam4.115"},{"key":"2142_CR5","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1200\/JCO.2007.15.1829","volume":"26","author":"CE Eyler","year":"2008","unstructured":"Eyler CE, Rich JN. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol. 2008;26:2839\u201345.","journal-title":"J Clin Oncol"},{"key":"2142_CR6","doi-asserted-by":"crossref","unstructured":"Morrison R, Schleicher SM, Sun Y, Niermann KJ, Kim S, Spratt DE, Chung CH, Lu. Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. J Oncol. 2011;2011:941876.","DOI":"10.1155\/2011\/941876"},{"key":"2142_CR7","doi-asserted-by":"crossref","unstructured":"Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES. Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening. Cell. 2009;138:1\u201315.","DOI":"10.1016\/j.cell.2009.06.034"},{"key":"2142_CR8","doi-asserted-by":"crossref","unstructured":"Bardsley MR, Horv\u00e1th VJ, Asuzu DT, Lorincz A, Redelman D, Hayashi Y, Popko LN, Young DL, Lomberk GA, Urrutia RA, Farrugia G, Rubin BP, Ordog T. Kitlow stem cells cause resistance to Kit\/platelet-derived growth factor alpha inhibitors in murine gastrointestinal stromal tumors. Gastroenterology. 2010;139:942\u201352.","DOI":"10.1053\/j.gastro.2010.05.083"},{"key":"2142_CR9","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1245\/s10434-011-1561-2","volume":"18","author":"T-T Dong","year":"2011","unstructured":"Dong T-T, Zhou H-M, Wang L-L, Feng B, Lv B, Zheng M-H. Salinomycin selectively targets \u201cCD133+\u201d cell subpopulations and decreases malignant traits in colorectal cancer lines. Ann Surg Oncol. 2011;18:1797\u2013804.","journal-title":"Ann Surg Oncol"},{"key":"2142_CR10","doi-asserted-by":"crossref","first-page":"e79798","DOI":"10.1371\/journal.pone.0079798","volume":"8","author":"L Larzabal","year":"2013","unstructured":"Larzabal L, El-Nikhely N, Redrado M, Seeger W, Savai R, Calvo A. Differential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasis. PLoS One. 2013;8:e79798.","journal-title":"PLoS One"},{"key":"2142_CR11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/1471-2407-12-466","volume":"12","author":"T Lieke","year":"2012","unstructured":"Lieke T, Ramackers W, Bergmann S, Klempnauer J, Winkler M, Klose J. Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro. BMC Cancer. 2012;12:466.","journal-title":"BMC Cancer"},{"key":"2142_CR12","doi-asserted-by":"crossref","unstructured":"Wang F, He L, Dai W-Q, Xu Y-P, Wu D, Lin C-L, Wu S-M, Cheng P, Zhang Y, Shen M, Wang C-F, Lu J, Zhou Y-Q, Xu X-F, Xu L, Guo C-Y. Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo. PLoS One. 2012;7:e50638.","DOI":"10.1371\/journal.pone.0050638"},{"key":"2142_CR13","unstructured":"Jangamreddy JR, Ghavami S, Grabarek J, Kratz G, Wiechec E, Fredriksson B-A, Rao Pariti RK, Cie\u015blar-Pobuda A, Panigrahi S, \u0141os MJ. Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells. Biochim Biophys Acta. 1833;2013:2057\u201369."},{"key":"2142_CR14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1476-4598-13-16","volume":"13","author":"F Kopp","year":"2014","unstructured":"Kopp F, Hermawan A, Oak PS, Herrmann A, Wagner E, Roidl A. Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration. Mol Cancer. 2014;13:16.","journal-title":"Mol Cancer"},{"key":"2142_CR15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canlet.2014.12.037","volume":"358","author":"M Schenk","year":"2015","unstructured":"Schenk M, Aykut B, Teske C, Giese NA, Weitz J, Welsch T. Salinomycin inhibits growth of pancreatic cancer and cancer cell migration by disruption of actin stress fiber integrity. Cancer Lett. 2015;358:161\u20139.","journal-title":"Cancer Lett"},{"key":"2142_CR16","doi-asserted-by":"crossref","first-page":"13253","DOI":"10.1073\/pnas.1110431108","volume":"108","author":"D Lu","year":"2011","unstructured":"Lu D, Choi MY, Yu J, Castro JE, Kipps TJ, Carson DA. Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proc Natl Acad Sci U S A. 2011;108:13253\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2142_CR17","doi-asserted-by":"crossref","unstructured":"Mao J, Fan S, Ma W, Fan P, Wang B, Zhang J, Yu X, Wang L, Song B, Li L. Roles of Wnt\/\u03b2-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment. Cell Death Dis. 2014;5:e1039.","DOI":"10.1038\/cddis.2013.515"},{"issue":"10","key":"2142_CR18","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/jcb.24850","volume":"115","author":"W Lu","year":"2014","unstructured":"Lu W, Li Y. Salinomycin suppresses LRP6 expression and inhibits both Wnt\/\u03b2-catenin and mTORC1 signaling in breast and prostate cancer cells. J Cell Biochem. 2014;115(10):1799\u2013807.","journal-title":"J Cell Biochem"},{"key":"2142_CR19","doi-asserted-by":"crossref","unstructured":"Lu Y, Ma W, Mao J, Yu X, Hou Z, Fan S, Song B, Wang H, Li J, Kang L, Liu P, Liu Q, Li L. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling. Chem Biol Interact. 2015;228:100\u20137.","DOI":"10.1016\/j.cbi.2014.12.002"},{"key":"2142_CR20","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bbrc.2010.03.138","volume":"394","author":"D Fuchs","year":"2010","unstructured":"Fuchs D, Daniel V, Sadeghi M, Opelz G, Naujokat C. Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun. 2010;394:1098\u2013104.","journal-title":"Biochem Biophys Res Commun"},{"key":"2142_CR21","doi-asserted-by":"crossref","unstructured":"Riccioni R, Dupuis ML, Bernabei M, Petrucci E, Pasquini L, Mariani G, Cianfriglia M, Testa U. The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. Blood Cells Mol Dis. 2010;45:86\u201392.","DOI":"10.1016\/j.bcmd.2010.03.008"},{"key":"2142_CR22","doi-asserted-by":"crossref","unstructured":"Ketola K, Hilvo M, Hy\u00f6tyl\u00e4inen T, Vuoristo A, Ruskeep\u00e4\u00e4 A-L, Ore\u0161i\u010d M, Kallioniemi O, Iljin K. Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress. Br J Cancer. 2012;106:99\u2013106.","DOI":"10.1038\/bjc.2011.530"},{"key":"2142_CR23","doi-asserted-by":"crossref","first-page":"e44132","DOI":"10.1371\/journal.pone.0044132","volume":"7","author":"B Verdoodt","year":"2012","unstructured":"Verdoodt B, Vogt M, Schmitz I, Liffers ST, Tannapfel A, Mirmohammadsadegh A. Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species. PLoS One. 2012;7:e44132.","journal-title":"PLoS One"},{"key":"2142_CR24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/1471-2407-14-591","volume":"14","author":"D Wang","year":"2014","unstructured":"Wang D, Upadhyaya B, Liu Y, Knudsen D, Dey M. Phenethyl isothiocyanate upregulates death receptors 4 and 5 and inhibits proliferation in human cancer stem-like cells. BMC Cancer. 2014;14:591.","journal-title":"BMC Cancer"},{"key":"2142_CR25","doi-asserted-by":"crossref","unstructured":"Kim KY, Yu SN, Lee SY, Chun SS, Choi YL, Park YM, Song CS, Chatterjee B, Ahn SC. Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization. Biochem Biophys Res Commun. 2011;413:80\u20136.","DOI":"10.1016\/j.bbrc.2011.08.054"},{"key":"2142_CR26","doi-asserted-by":"crossref","unstructured":"Kim J-H, Chae M, Kim WK, Kim Y-J, Kang HS, Kim HS, Yoon S. Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein. Br J Pharmacol. 2011;162:773\u201384.","DOI":"10.1111\/j.1476-5381.2010.01089.x"},{"key":"2142_CR27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/AAC.9.4.655","volume":"9","author":"M Mitani","year":"1976","unstructured":"Mitani M, Yamanishi T, Miyazaki Y, Otake N. Salinomycin effects on mitochondrial ion translocation and respiration. Antimicrob Agents Chemother. 1976;9:655\u201360.","journal-title":"Antimicrob Agents Chemother"},{"key":"2142_CR28","first-page":"36","volume":"2","author":"C Naujokata","year":"2013","unstructured":"Naujokata C, Lauferc S. Targeting cancer stem cells with defined compounds and drugs. J Cancer Res. 2013;2:36\u201367.","journal-title":"J Cancer Res"},{"key":"2142_CR29","doi-asserted-by":"crossref","first-page":"950658","DOI":"10.1155\/2012\/950658","volume":"2012","author":"C Naujokat","year":"2012","unstructured":"Naujokat C, Steinhart R. Salinomycin as a drug for targeting human cancer stem cells. J Biomed Biotechnol. 2012;2012:950658.","journal-title":"J Biomed Biotechnol"},{"key":"2142_CR30","doi-asserted-by":"crossref","first-page":"9944","DOI":"10.1039\/c3cc45983g","volume":"49","author":"B Borgstr\u00f6m","year":"2013","unstructured":"Borgstr\u00f6m B, Huang X, Po\u0161ta M, Hegardt C, Oredsson S, Strand D. Synthetic modification of salinomycin: selective O-acylation and biological evaluation. Chem Commun (Camb). 2013;49:9944\u20136.","journal-title":"Chem Commun (Camb)"},{"key":"2142_CR31","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1271\/bbb1961.40.1633","volume":"40","author":"Y Miyazaki","year":"1976","unstructured":"Miyazaki Y, Kinashi H, Otake N, Mitani M, Yamanishi T. Chemical Modification and Structure-Activity Correlation of Salinomycin. Agric Biol Chem. 1976;40:1633\u201340.","journal-title":"Agric Biol Chem"},{"key":"2142_CR32","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1016\/j.bmcl.2012.09.068","volume":"22","author":"A Huczy\u0144ski","year":"2012","unstructured":"Huczy\u0144ski A, Janczak J, Antoszczak M, Wietrzyk J, Maj E, Brzezinski B. Antiproliferative activity of salinomycin and its derivatives. Bioorg Med Chem Lett. 2012;22:7146\u201350.","journal-title":"Bioorg Med Chem Lett"},{"key":"2142_CR33","doi-asserted-by":"crossref","unstructured":"Antoszczak M, Popiel K, Stefa\u0144ska J, Wietrzyk J, Maj E, Janczak J, Michalska G, Brzezinski B, Huczy\u0144ski A. Synthesis, cytotoxicity and antibacterial activity of new esters of polyether antibiotic - salinomycin. Eur J Med Chem. 2014;76:435\u201344.","DOI":"10.1016\/j.ejmech.2014.02.031"},{"key":"2142_CR34","doi-asserted-by":"crossref","unstructured":"Huczy\u0144ski A, Antoszczak M, Kleczewska N, Lewandowska M, Maj E, Stefa\u0144ska J, Wietrzyk J, Janczak J, Celewicz L. Synthesis and biological activity of salinomycin conjugates with floxuridine. Eur J Med Chem. 2015;93:33\u201341.","DOI":"10.1016\/j.ejmech.2015.01.045"},{"key":"2142_CR35","doi-asserted-by":"crossref","unstructured":"Huang X, Borgstr\u00f6m B, M\u00e5nsson L, Persson L, Oredsson S, Hegardt C, Strand D. Semisynthesis of SY-1 for investigation of breast cancer stem cell selectivity of C-Ring-modified salinomycin analogues. ACS Chem Biol. 2014;9:1587\u201394.","DOI":"10.1021\/cb5002153"},{"key":"2142_CR36","doi-asserted-by":"crossref","unstructured":"Tanner M, Kapanen AI, Junttila T, Raheem O, Grenman S, Elo J, Elenius K, Isola J. Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer. Mol Cancer Ther. 2004;3:1585\u201392.","DOI":"10.1158\/1535-7163.1585.3.12"},{"key":"2142_CR37","doi-asserted-by":"crossref","unstructured":"J\u00f6nsson G, Staaf J, Olsson E, Heidenblad M, Vallon-Christersson J, Osoegawa K, de Jong P, Oredsson S, Ringn\u00e9r M, H\u00f6glund M BA. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization. Genes Chromosomes Cancer. 2007;46:543\u201358.","DOI":"10.1002\/gcc.20438"},{"key":"2142_CR38","doi-asserted-by":"crossref","unstructured":"Olsson E, Honeth G, Bendahl P-O, Saal LH, Gruvberger-Saal S, Ringn\u00e9r M, Vallon-Christersson J, J\u00f6nsson G, Holm K, L\u00f6vgren K, Fern\u00f6 M, Grabau D, Borg \u00c5, Hegardt C. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers. BMC Cancer. 2011;11:418.","DOI":"10.1186\/1471-2407-11-418"},{"key":"2142_CR39","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.4161\/cc.10.22.17976","volume":"10","author":"S Cuf\u00ed","year":"2011","unstructured":"Cuf\u00ed S, Vazquez-Martin A, Oliveras-Ferraros C, Martin-Castillo B, Vellon L, Menendez J a. Autophagy positively regulates the CD44\u2009+\u2009CD24 -\/low breast cancer stem-like phenotype. Cell Cycle. 2011;10:3871\u201385.","journal-title":"Cell Cycle"},{"key":"2142_CR40","doi-asserted-by":"crossref","unstructured":"Cufi S, Corominas-Faja B, Vazquez-Martin A, Oliveras-Ferraros C, Dorca J, Bosch-Barrera J, Martin-Castillo B, Menendez JA. Metformin-induced preferential killing of breast cancer initiating CD44\u2009+\u2009CD24-\/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts. Oncotarget. 2012;3:395\u20138.","DOI":"10.18632\/oncotarget.488"},{"key":"2142_CR41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00726-013-1621-y","volume":"46","author":"TM Silva","year":"2014","unstructured":"Silva TM, Fiuza SM, Marques MPM, Persson L, Oredsson S. Increased breast cancer cell toxicity by palladination of the polyamine analogue N (1), N (11)-bis(ethyl)norspermine. Amino Acids. 2014;46:339\u201352.","journal-title":"Amino Acids"},{"key":"2142_CR42","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/CAD.0b013e32833f2f77","volume":"21","author":"H Cirenajwis","year":"2010","unstructured":"Cirenajwis H, Smiljanic S, Honeth G, Hegardt C, Marton LJ, Oredsson SM. Reduction of the putative CD44\u2009+\u2009CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047. Anticancer Drugs. 2010;21:897\u2013906.","journal-title":"Anticancer Drugs"},{"key":"2142_CR43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/(SICI)1097-4644(19991001)75:1<46::AID-JCB5>3.0.CO;2-N","volume":"75","author":"K Alm","year":"1999","unstructured":"Alm K, Berntsson P, Oredsson SM. Topoisomerase II is nonfunctional in polyamine-depleted cells. J Cell Biochem. 1999;75:46\u201355.","journal-title":"J Cell Biochem"},{"key":"2142_CR44","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100:3983\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2142_CR45","doi-asserted-by":"crossref","unstructured":"Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1:555\u201367.","DOI":"10.1016\/j.stem.2007.08.014"},{"key":"2142_CR46","doi-asserted-by":"crossref","unstructured":"Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS. In vitro propagation and transcriptional profiling of human mammary stem \/ progenitor cells. Genes Dev. 2003;17:1253\u201370.","DOI":"10.1101\/gad.1061803"},{"key":"2142_CR47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10911-009-9110-3","volume":"14","author":"BG Hollier","year":"2009","unstructured":"Hollier BG, Evans K, Mani SA. The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J Mammary Gland Biol Neoplasia. 2009;14:29\u201343.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2142_CR48","doi-asserted-by":"crossref","unstructured":"Mani S a, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg R a. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704\u201315.","DOI":"10.1016\/j.cell.2008.03.027"},{"key":"2142_CR49","doi-asserted-by":"crossref","unstructured":"Santisteban M, Reiman JM, Asiedu MK, Behrens MD, Nassar A, Kalli KR, Haluska P, Ingle JN, Hartmann LC, Manjili MH, Radisky DC, Ferrone S, Knutson KL. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res. 2009;69:2887\u201395.","DOI":"10.1158\/0008-5472.CAN-08-3343"},{"key":"2142_CR50","doi-asserted-by":"crossref","first-page":"a002915","DOI":"10.1101\/cshperspect.a002915","volume":"2","author":"J Heuberger","year":"2010","unstructured":"Heuberger J, Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol. 2010;2:a002915.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2142_CR51","doi-asserted-by":"crossref","unstructured":"Tian X, Liu Z, Niu B, Zhang J, Tan TK, Lee SR, Zhao Y, Harris DCH, Zheng G. E-cadherin\/\u03b2-catenin complex and the epithelial barrier. J Biomed Biotechnol. 2011;2011:567305.","DOI":"10.1155\/2011\/567305"},{"key":"2142_CR52","doi-asserted-by":"crossref","unstructured":"Yoon MJ, Kang YJ, Kim IY, Kim EH, Lee JA, Lim JH, Kwon TK, Choi KS. Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation. Carcinogenesis. 2013;34:1918\u201328.","DOI":"10.1093\/carcin\/bgt137"},{"key":"2142_CR53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.tips.2014.06.006","volume":"35","author":"FM Davis","year":"2014","unstructured":"Davis FM, Stewart TA, Thompson EW, Monteith GR. Targeting EMT in cancer: opportunities for pharmacological intervention. Trends Pharmacol Sci. 2014;35:479\u201388.","journal-title":"Trends Pharmacol Sci"},{"key":"2142_CR54","doi-asserted-by":"crossref","unstructured":"Scherzed A, Hackenberg S, Froelich K, Rak K, Technau A, Radeloff A, N\u00f6th U, Koehler C, Hagen R, Kleinsasser N. Effects of salinomycin on human bone marrow-derived mesenchymal stem cells in vitro. Toxicol Lett. 2013;218:207\u201314.","DOI":"10.1016\/j.toxlet.2013.02.001"},{"key":"2142_CR55","doi-asserted-by":"crossref","unstructured":"Kusunoki S, Kato K, Tabu K, Inagaki T, Okabe H, Kaneda H, Suga S, Terao Y, Taga T, Takeda S. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells. Gynecol Oncol. 2013;129:598\u2013605.","DOI":"10.1016\/j.ygyno.2013.03.005"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2142-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:08:40Z","timestamp":1718363320000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2407\/16\/145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,23]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2142"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2142-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,23]]},"article-number":"145"}}